Ten63 Therapeutics Is A Biotechnology Company Based In Durhamnorth Carolinafounded In 2017It Focuses On Computational Drug Discoveryaiming To Create First In Class And Best In Class Therapeutics For Targets That Have Traditionally Been Difficult To Drugthe Company Is A Spin Out From Duke University And Tti Chicago The Core Of Ten63 S Work Is Its Proprietary Beyond Platformwhich Combines Ai Driven Computational Chemistry With Physics Based Modelsthis Platform Uses Advanced Algorithms And Machine Learning To Efficiently Explore Chemical Spaces And Optimize Drug Candidatesparticularly For Oncology Targetsten63 Collaborates With Pharmaceutical Companiesincluding Boehringer Ingelheimto Leverage Their Expertise In Discovering New Molecules Across Various Therapeutic Areasthe Company Has Raised A Total Of $18 05 Million In Fundingincluding A Significant Series A Roundten63 Is Committed To Addressing High Unmet Medical Needs Through Innovative Drug Discovery Methods
